Hydroxychloroquine (HCQS) From Ipca

The world is battling the coronavirus outbreak that risks the survival human beings. As it spreads via human contact and direct contact with the coronavirus, many countries have started lockdowns to prevent movement and social gatherings. This has minimized the spread of COVID-19 disease. But to fight coronavirus we need an effective vaccine.

A recent study has revealed that hydroxychloroquine (HCQS) and chloroquine may be helpful in treating COVID-19, though research is still going on. Hydroxychloroquine is used to treat malaria, lupus, rheumatoid arthritis and some other diseases. HCQS 200 mg is an anti-malaria tablet that may be useful in treating COVID-19. HCQS 200 mg tablets are manufactured in IPCA Laboratories Pvt. Ltd, Mumbai. Hydroxychloroquine should be taken only when prescribed by the doctor. HCQS is an oral tablet and must be taken in the correct dosage.

There are various side effects of HCQS like drowsiness, fever, stomach ache, headache, and skin problems. If you experience severe side effects like loss of vision or hearing after taking the tablet, talk to your doctor immediately. A high dosage of HCQS can be fatal or cause heart disease.

Before taking HCQS tablets, it is essential that you inform your doctor about any other drugs you are taking, as HCQS in combination with other drugs can be harmful. In some cases, patients may experience mental health problems or disturbances when on HCQS medication. If you experience suicidal thoughts while on HCQS, you must talk to your doctor about this.

Always consult a doctor before starting the medication.